Tag Archives: Purdue Pharma

Financial Daily Dose 10.14.2019 | Top Story: WeWork Board Weighing Bailout Options from SoftBank and JPMorgan

BY: Michael D. Reif | October 14, 2019

We Work’s largest investor, SoftBank, is reportedly sketching out plans in which it would drop billions of additional money on the company in return for giving Masa Son control of WeWork “and further sidelin[ing] its founder Adam Neumann.” WeWork’s board is also considering a JPMorgan option, hoping that the bank could help it raise billions … Continue reading

Financial Daily Dose 9.9.2019 | Top Story: Fed on Track to Cut Rates Again in September

BY: Michael D. Reif | September 9, 2019

Friday remarks from Fed Chair Powell in Zurich confirmed the central bank’s dedication to keeping the US economic expansion on track and appear to have signaled the Fed’s plan to cut interest rates for a second time this year – NYTimes and WSJ Last week’s jobs numbers don’t appear to significantly alter that plan – … Continue reading

Financial Daily Dose 8.28.2019 | Top Story: British PM to Suspend Parliament in Bid to Push Through Brexit

BY: Michael D. Reif | August 28, 2019

Man-of-the-people PM Boris Johnson is set to as the Queen to suspend parliament for 5 weeks in an attempt to squeeze the time for opposition to the October 31st Brexit deadline, a move that’s prompting concerns about a constitutional crisis in the UK – Bloomberg and NYTimes and WSJ and MarketWatch Mega-reunification news late yesterday, … Continue reading

Your Daily Dose of Financial News

BY: Michael D. Reif | March 27, 2019

Back at it, and not quiet when I was gone.  Let’s get caught up . . . OxyContin-maker Purdue Pharma and its owners, the Sackler family, reached a deal this week with the state of Oklahoma in which they will pay “$270 million to avoid going to a state court trial over the company’s role … Continue reading

Your Daily Dose of Financial News

BY: Michael D. Reif | March 5, 2019

OxyContin maker Purdue Pharm is prepping for a possible bankruptcy filing “as it seeks to contain liability from hundreds of lawsuits alleging it fueled the nation’s opioid epidemic.” Officially, the company went on the record saying it has “ample liquidity” – WSJ and Bloomberg and MarketWatch San Francisco federal judge Charles Breyer took the rare … Continue reading